IS8404A - Nogo-A binding með aukinni sækni og lyfjafræðilegnotkun hennar - Google Patents

Nogo-A binding með aukinni sækni og lyfjafræðilegnotkun hennar

Info

Publication number
IS8404A
IS8404A IS8404A IS8404A IS8404A IS 8404 A IS8404 A IS 8404A IS 8404 A IS8404 A IS 8404A IS 8404 A IS8404 A IS 8404A IS 8404 A IS8404 A IS 8404A
Authority
IS
Iceland
Prior art keywords
nogo
binding
increased affinity
pharmacological use
pharmacological
Prior art date
Application number
IS8404A
Other languages
English (en)
Inventor
Barske Carmen
Frentzel Stefan
Khusro Mir Anis
E. Schwab Martin
Vitaliti Alessandra
Original Assignee
Novartis Ag
University Of Zurich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, University Of Zurich filed Critical Novartis Ag
Publication of IS8404A publication Critical patent/IS8404A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS8404A 2003-09-19 2006-04-10 Nogo-A binding með aukinni sækni og lyfjafræðilegnotkun hennar IS8404A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321997.9A GB0321997D0 (en) 2003-09-19 2003-09-19 Organic compound
PCT/EP2004/010489 WO2005028508A2 (en) 2003-09-19 2004-09-17 Nogo-a binding with enhanced affinity and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
IS8404A true IS8404A (is) 2006-04-10

Family

ID=29266310

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8404A IS8404A (is) 2003-09-19 2006-04-10 Nogo-A binding með aukinni sækni og lyfjafræðilegnotkun hennar

Country Status (25)

Country Link
US (2) US20090181023A1 (is)
EP (3) EP1668033A2 (is)
JP (1) JP2007527232A (is)
KR (1) KR20060119982A (is)
CN (1) CN1878792A (is)
AR (1) AR045671A1 (is)
AU (2) AU2004274164B2 (is)
BR (1) BRPI0414174B8 (is)
CA (1) CA2538725C (is)
CO (1) CO5680457A2 (is)
EC (1) ECSP066431A (is)
GB (1) GB0321997D0 (is)
IL (2) IL174145A (is)
IS (1) IS8404A (is)
MA (1) MA28088A1 (is)
MY (2) MY161068A (is)
NO (1) NO20061678L (is)
NZ (1) NZ545679A (is)
PE (1) PE20050949A1 (is)
RU (1) RU2380377C2 (is)
SG (1) SG146660A1 (is)
TN (1) TNSN06085A1 (is)
TW (1) TWI372060B (is)
WO (1) WO2005028508A2 (is)
ZA (1) ZA200601842B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2213684A3 (en) * 2003-12-22 2011-05-18 Glaxo Group Limited Nogo-a antibodies for the treatment of Alzheimer disease
SG157418A1 (en) * 2004-12-01 2009-12-29 Univ Singapore Nogo a protein fragments as neuronal network- interacting peptides
HRP20120851T1 (hr) * 2005-07-05 2012-11-30 Glaxo Group Limited Humanizirana protutijela specifiäśna za nogo-a i njihova farmaceutska upotreba
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
MX2010004831A (es) * 2007-11-02 2010-05-21 Novartis Ag Moleculas de enlace de nogo-a mejoradas y uso farmaceutico de las mismas.
US8828390B2 (en) 2010-07-09 2014-09-09 Universitat Zurich Uses of NOGO-A inhibitors and related methods
AU2013285493A1 (en) 2012-07-05 2015-01-22 Glaxo Group Limited Optimum dose regime of an anti-Nogo-A antibody in the treatment of amyotrophic lateral sclerosis
CN113527462B (zh) * 2020-04-22 2023-05-23 北京大学 一种具有镇痛作用的小分子肽及其特异性抗体
CN114470197B (zh) * 2022-02-16 2023-10-03 天津长和生物技术有限公司 低氧培养的hUCMSC联合NogoA抗体在脊髓损伤治疗中的应用
WO2024041450A1 (zh) * 2022-08-22 2024-02-29 舒泰神（北京）生物制药股份有限公司 特异性识别Nogo-A的抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308573D0 (en) 1983-03-29 1983-05-05 British Nuclear Fuels Ltd Filament impregnating/coating
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
ES2085326T3 (es) 1989-02-13 1996-06-01 Schering Ag Activador de plasminogeno salivar del murcielago vampiro vpa-alfa1.
JP2002522016A (ja) * 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ
HK1051543A1 (zh) * 2000-01-12 2003-08-08 Yale University Nogo受体介导的轴突生长封锁
AR037456A1 (es) * 2001-11-30 2004-11-10 Biogen Inc Anticuerpos contra proteinas quimiotacticas monocitarias
GB0228832D0 (en) * 2002-12-10 2003-01-15 Novartis Ag Organic compound
EP2213684A3 (en) * 2003-12-22 2011-05-18 Glaxo Group Limited Nogo-a antibodies for the treatment of Alzheimer disease

Also Published As

Publication number Publication date
IL203007A (en) 2013-10-31
AU2004274164A1 (en) 2005-03-31
WO2005028508A3 (en) 2005-07-07
ECSP066431A (es) 2006-09-18
GB0321997D0 (en) 2003-10-22
AR045671A1 (es) 2005-11-02
BRPI0414174B1 (pt) 2019-06-04
PE20050949A1 (es) 2005-12-16
WO2005028508A2 (en) 2005-03-31
NZ545679A (en) 2009-11-27
AU2009200237A1 (en) 2009-02-12
EP1668033A2 (en) 2006-06-14
KR20060119982A (ko) 2006-11-24
NO20061678L (no) 2006-06-16
IL174145A0 (en) 2006-08-01
MA28088A1 (fr) 2006-08-01
MY161068A (en) 2017-04-14
CN1878792A (zh) 2006-12-13
CA2538725C (en) 2010-12-21
EP2423225A3 (en) 2013-03-20
SG146660A1 (en) 2008-10-30
BRPI0414174B8 (pt) 2021-05-25
ZA200601842B (en) 2007-09-26
RU2380377C2 (ru) 2010-01-27
JP2007527232A (ja) 2007-09-27
IL203007A0 (en) 2011-08-01
TNSN06085A1 (en) 2007-10-03
TW200517123A (en) 2005-06-01
US20110008334A1 (en) 2011-01-13
EP2248827A1 (en) 2010-11-10
EP2423225A2 (en) 2012-02-29
MY158078A (en) 2016-08-30
CO5680457A2 (es) 2006-09-29
AU2009200237B2 (en) 2011-05-19
RU2006112849A (ru) 2007-12-20
AU2004274164B2 (en) 2009-02-05
BRPI0414174A (pt) 2006-10-31
CA2538725A1 (en) 2005-03-31
TWI372060B (en) 2012-09-11
US20090181023A1 (en) 2009-07-16
IL174145A (en) 2010-11-30

Similar Documents

Publication Publication Date Title
DK1691837T3 (da) IP-10-antistoffer og anvendelse heraf
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
IL183353A0 (en) Polypeptides that bind br3 and uses thereof
IS7115A (is) TACI og BR3 fjölpeptíð og notkun á þeim
IL182554A0 (en) Anti-addl antibodies and uses thereof
IL179300A0 (en) Novel-antigen-binding polypeptides and their uses
IS2944B (is) Fjölliðu-samrunaefnasambönd með minnkaða mótefniseiginleika, aðferðir við tilbúning og notkun þeirra
IS8054A (is) Kannabinóíð viðtaka bindlar og notkun þeirra
IS8137A (is) Kannabinóíð viðtaka bindlar og notkun þeirra
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
NO2016020I2 (no) Imidacloprid og Flumetrin
ATE472576T1 (de) Polyalkenamine mit verbesserten anwendungseigenschaften
DK1737961T3 (da) Modificerede bouganin proteiner, cytotoxiner og fremgangsmåder og anvendelser deraf
IL203007A0 (en) Nogo-a binding with enhanced affinity and pharmaceutical use thereof
ZA200608100B (en) IRTA-5 antibodies and their uses
ZA200703406B (en) Anti-ADDL antibodies and uses thereof
DK1663291T3 (da) Rekombinante lubricinmolekyler og anvendelser deraf
DK1736541T3 (da) Nyt modificeret galectin 9-protein og anvendelse heraf
DE112004000857D2 (de) Eisen-Chrom-Aluminium-Legierung
DK1829874T3 (da) Tricyklisk forbindelse og anvendelse deraf
EP1960523A4 (en) MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF
DK1840121T3 (da) Glycinderivat og anvendelse heraf
GB0414055D0 (en) Specific binding members and uses thereof
DE60238792D1 (de) Neues meloidogyne-resistenzgen und dessen nutzung